ATE435234T1 - Hetero-oligomere hiv-hüllproteine - Google Patents
Hetero-oligomere hiv-hüllproteineInfo
- Publication number
- ATE435234T1 ATE435234T1 AT05855755T AT05855755T ATE435234T1 AT E435234 T1 ATE435234 T1 AT E435234T1 AT 05855755 T AT05855755 T AT 05855755T AT 05855755 T AT05855755 T AT 05855755T AT E435234 T1 ATE435234 T1 AT E435234T1
- Authority
- AT
- Austria
- Prior art keywords
- hiv
- different
- heterotrimer
- env glycoprotein
- hiv envelope
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 5
- 108010078428 env Gene Products Proteins 0.000 abstract 4
- 239000000178 monomer Substances 0.000 abstract 4
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64032904P | 2004-12-29 | 2004-12-29 | |
| PCT/US2005/047244 WO2006071933A2 (en) | 2004-12-29 | 2005-12-28 | Hetero-oligomeric hiv envelope proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE435234T1 true ATE435234T1 (de) | 2009-07-15 |
Family
ID=36615506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05855755T ATE435234T1 (de) | 2004-12-29 | 2005-12-28 | Hetero-oligomere hiv-hüllproteine |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080248063A1 (de) |
| EP (2) | EP1831247B1 (de) |
| CN (1) | CN101094862A (de) |
| AT (1) | ATE435234T1 (de) |
| DE (1) | DE602005015256D1 (de) |
| DK (1) | DK1831247T3 (de) |
| ES (1) | ES2328507T3 (de) |
| WO (1) | WO2006071933A2 (de) |
| ZA (1) | ZA200706186B (de) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL46110C (de) | 1936-08-07 | 1939-02-15 | ||
| US5652138A (en) | 1992-09-30 | 1997-07-29 | The Scripps Research Institute | Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| US6716429B1 (en) * | 1997-10-01 | 2004-04-06 | Dana-Farber Cancer Institute, Inc. | Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp 41 glycoprotein ectodomain |
| FR2781676B1 (fr) * | 1998-07-31 | 2004-04-02 | Pasteur Merieux Serums Vacc | Trimere du produit d'expression du gene env de hiv |
| WO2001019958A2 (en) | 1999-09-17 | 2001-03-22 | Dana-Farber Cancer Institute, Inc. | Stabilized soluble glycoprotein trimers |
| EP1246607B1 (de) | 1999-12-30 | 2007-06-27 | Dana-Farber Cancer Institute, Inc. | Proteoliposomen, die ein integral membranprotein mit einer oder memhreren transmembrandomänen enthalten |
| WO2003022869A2 (en) * | 2001-09-06 | 2003-03-20 | Progenics Pharmaceuticals, Inc. | Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
-
2005
- 2005-12-28 DK DK05855755T patent/DK1831247T3/da active
- 2005-12-28 AT AT05855755T patent/ATE435234T1/de active
- 2005-12-28 EP EP05855755A patent/EP1831247B1/de not_active Expired - Lifetime
- 2005-12-28 ES ES05855755T patent/ES2328507T3/es not_active Expired - Lifetime
- 2005-12-28 DE DE602005015256T patent/DE602005015256D1/de not_active Expired - Lifetime
- 2005-12-28 WO PCT/US2005/047244 patent/WO2006071933A2/en not_active Ceased
- 2005-12-28 EP EP09004681A patent/EP2088155A1/de not_active Withdrawn
- 2005-12-28 US US11/722,336 patent/US20080248063A1/en not_active Abandoned
- 2005-12-28 CN CNA2005800455415A patent/CN101094862A/zh active Pending
-
2007
- 2007-07-26 ZA ZA200706186A patent/ZA200706186B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006071933A2 (en) | 2006-07-06 |
| HK1107998A1 (en) | 2008-04-25 |
| WO2006071933A3 (en) | 2007-02-15 |
| EP2088155A1 (de) | 2009-08-12 |
| ZA200706186B (en) | 2008-06-25 |
| US20080248063A1 (en) | 2008-10-09 |
| ES2328507T3 (es) | 2009-11-13 |
| DE602005015256D1 (de) | 2009-08-13 |
| DK1831247T3 (da) | 2009-10-12 |
| EP1831247B1 (de) | 2009-07-01 |
| CN101094862A (zh) | 2007-12-26 |
| EP1831247A2 (de) | 2007-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yang et al. | Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins | |
| He et al. | Identification of a critical motif for the human immunodeficiency virus type 1 (HIV-1) gp41 core structure: implications for designing novel anti-HIV fusion inhibitors | |
| JP2019501882A5 (de) | ||
| DK2267452T3 (da) | Opløseligt kompleks omfattende et retroviralt overfladeglycoprotein | |
| TW200621806A (en) | Vaccine | |
| WO2008063331A3 (en) | Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric complexes, and uses thereof | |
| MY136081A (en) | Modified hiv - 1gag p17 peptide and immunogenic composition | |
| DK1159298T3 (da) | HIV-peptider, antigener og vaccinekompositioner | |
| BRPI0511982A (pt) | compostos antiviróticos heterocìclicos | |
| JP2010521147A5 (de) | ||
| JP2017501986A5 (ja) | 二重特異性ｈｉｖ−１中和抗体 | |
| WO2007149491A3 (en) | Soluble stabilized trimeric hiv env proteins and uses thereof | |
| ATE435234T1 (de) | Hetero-oligomere hiv-hüllproteine | |
| ES2673972T3 (es) | Formas solubles de la glicoproteína G de los virus hendra y nipah | |
| EP2567967A3 (de) | Verwendung von adenoviralen Vektoren zur Erzeugung einer Immunantwort | |
| JP2006503849A5 (de) | ||
| ATE509942T1 (de) | Nichtproteolysierbare oligopeptide, die das glycoprotein gp41 von hiv inhibieren | |
| WO2002064154A3 (en) | Methods and compositions for inhibiting hiv-coreceptor interactions | |
| ATE531809T1 (de) | Neues simianes t-zell-lymphotropes virus | |
| WO2004027066A3 (fr) | Protéine recombinante chimérique et diagnostic in vitro du hiv | |
| Ecker et al. | Overexpression and purification of a recombinant chimeric HIV type 2/HIV type 1 envelope peptide and application in an accelerated immunobased HIV type 1/2 antibody detection system (AIBS): a new rapid serological screening assay | |
| WO2023133435A3 (en) | Novel immunogens for influenza virus vaccines | |
| BR9715035A (pt) | Processo para produção da proteìna hìbrida | |
| CU23471A1 (es) | Péptido quimérico de la proteína de la transmembrana (gp41) y la proteína de la envoltura (gp120) del vih-1 | |
| Bianchi et al. | Covalent Trimeric Coiled Coils of the HIV gp41 HR1 Region are Extremely Potent and Broadly Neutralizing Inhibitors of Viral Infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1831247 Country of ref document: EP |
|
| UEP | Publication of translation of european patent specification |
Ref document number: 1831247 Country of ref document: EP |